Skip to main content
Log in

Diagnostik von Arzneimittelüberempfindlichkeiten

Diagnostics of drug hypersensitivity reactions

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Arzneimittelüberempfindlichkeiten machen etwa 25 % aller Nebenwirkungen auf Arzneimittel aus und lassen sich in allergische und pseudoallergische Arzneireaktionen differenzieren. Je nach Pathogenese und Klinik kann man anaphylaktische Sofort- und exanthematische Spätreaktionen verschiedenen klinischen Musters unterscheiden. Ihre diagnostische Abklärung beinhaltet eine umfassende, aber gleichermaßen auf die wichtigsten Parameter fokussierte Anamnese, Durchführung von Hauttests und ggf. Provokationstests sowie den möglichen ergänzenden Einsatz von In-vitro-Tests wie dem Basophilenaktivierungstest oder T‑zellulären Assays. Letztere können nicht nur wichtige zusätzliche Informationen liefern, sondern gerade im Fall sehr schwerer oder nicht durch Provokationstests weiter abklärbarer Arzneireaktionen entscheidende Befunde beisteuern. Ziele der Untersuchungen sind nicht nur der Nachweis einer Arzneimittelunverträglichkeit und die Detektion des auslösenden Medikaments, sondern auch die Aufdeckung des zugrunde liegenden Reaktionstyps und Identifizierung möglicher Alternativpräparate. All diese Informationen sind von hoher Bedeutung sowohl für eine fachkundige Beratung des Patienten als auch für die erforderlichen Präventivmaßnahmen zur Vermeidung erneuter Arzneimittelreaktionen.

Abstract

Drug hypersensitivity reactions comprise approximately 25% of all adverse drug reactions and can be classified into allergic and pseudoallergic drug reactions. Immediate type anaphylactic and delayed type rash reactions of various clinical patterns can be distinguished, depending on the pathogenesis and clinical symptoms. The diagnostic work-up encompasses a thorough but also focused evaluation of the medical history, skin tests and when indicated challenge tests. Furthermore, in vitro tests, such as basophil activation tests and T cell assays not only add valuable additional information but can also yield decisive results for the diagnosis, especially in cases of severe drug reactions or reactions which cannot be further clarified by provocation tests. The aim of these measurements is not only the proof of drug intolerance and the detection of the causal drug but also the disclosure of the type of adverse reaction and the identification of potential, tolerated alternative drugs. This information is very important for the counseling of the patient and for prevention of new drug hypersensitivity reactions in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Abbreviations

AGEP:

Akute generalisierte exanthematische Pustulose

AM:

Arzneimittel

AMÜ:

Arzneimittelüberempfindlichkeit

BAT:

Basophilenaktivierungstest

CAST:

„Cellular antigen stimulation test“

DRESS:

„Drug rash with eosinophilia and systemic symptoms“

EEM:

Erythema exsudativum multiforme

ELISpot Assay:

„Enyzme linked immunospot assay“

FACS:

„Fluorescence activated cell sorting“

HRA:

Histamin-Release-Assay

HSV:

Herpes-simplex-Virus

HT:

Hauttest

LTT:

Lymphozytentransformationstest

PT:

Provokationstest

SJS:

Stevens-Johnson-Syndrom

TEN:

Toxisch-epidermale Nekrolyse

Literatur

  1. Pfützner W (2012) Arzneimittelreaktionen. In: Plewig G, Landthaler M, Burgdorf WHC, Hertl M, Ruzicka T (Hrsg) Braun-Falcos Dermatologie, Venerolohie und Allergologie. Springer, Heidelberg, S 559–581

    Chapter  Google Scholar 

  2. Merk HF (2015) Allergische Arzneimittelreaktionen der Haut: Aktuelles zu Klinik, Diagnostik und Differentialdiagnostik. Akt Dermatol 41:407–417

    Article  Google Scholar 

  3. Brockow K, Przybilla B, Aberer W et al (2015) Guideline for the diagnosis of drug hypersensitivity reactions. Allergo J Int 24:94–105

    Article  PubMed  PubMed Central  Google Scholar 

  4. Demoly P, Adkinson NF, Brockow K et al (2014) International consensus on drug allergy. Allergy 69:420–437

    Article  CAS  PubMed  Google Scholar 

  5. Oussalah A, Mayorga C, Blanca M et al (2016) Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review. Allergy 71:443–462

    Article  CAS  PubMed  Google Scholar 

  6. Torres MJ, Blanca M, Fernandez J et al (2003) Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 58:961–972

    Article  CAS  PubMed  Google Scholar 

  7. Barbaud A (2014) Skin testing and patch testing in non-IgE-mediated drug allergy. Curr Allergy Asthma Rep 14:442. doi:10.1007/s11882-014-0442-8

    Article  PubMed  Google Scholar 

  8. Brockow K, Garvey LH, Aberer W et al (2013) Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 68:702–712

    Article  CAS  PubMed  Google Scholar 

  9. Romano A, Gaeta F, Valluzzi RL et al (2012) Diagnosing nonimmediate reactions to cephalosporins. J Allergy Clin Immunol 129:1166–1169

    Article  PubMed  Google Scholar 

  10. Brockow K, Romano A, Blanca M et al (2002) General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57:45–51

    CAS  PubMed  Google Scholar 

  11. Dickel H, Kreft B, Kuss O et al (2010) Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study. Contact Derm 62:294–302

    Article  PubMed  Google Scholar 

  12. Aberer W, Bircher A, Romano A et al (2003) Drug provocation testing in the diagnosis of drug hypersensitivity reactions. Allergy 58:854–863

    Article  CAS  PubMed  Google Scholar 

  13. Blanca M, Romano A, Torres MJ et al (2009) Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 64:183–193

    Article  CAS  PubMed  Google Scholar 

  14. Blanca M, Torres MJ, Garcia JJ et al (1999) Natural evolution of skin test sensitivity in patients allergic to ß‑lactam antibiotics. J Allergy Clin Immunol 103:918–294

    Article  CAS  PubMed  Google Scholar 

  15. Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C (2013) Diagnosis of penecillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy 68:1057–1064

    Article  CAS  PubMed  Google Scholar 

  16. Defrance C, Bousquet PJ, Demoly P (2011) Evaluating the negative predictive value of provocation tests with nonsteroidal anti-inflammatory drugs. Allergy 66:1410–1414

    Article  CAS  PubMed  Google Scholar 

  17. Demoly P, Romano A, Bothelo C et al (2010) Determining the negative predictive value of provocation tests with beta-lactams. Allergy 65:327–332

    Article  CAS  PubMed  Google Scholar 

  18. Hjortlund J, Mortz CG, Stage TB et al (2014) Positive serum specific IgE has a short half-life in patients with penicillin allergy and reversal does not always indicate tolerance. Clin Transl Allergy 4:34–43

    Article  PubMed  PubMed Central  Google Scholar 

  19. Mayorga C, Celik G, Rouzaire P (2016) In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 71:1103–1134

    Article  CAS  PubMed  Google Scholar 

  20. Hoffmann HJ, Santos AF, Mayorga C et al (2015) The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy 70:1393–1405

    Article  CAS  PubMed  Google Scholar 

  21. Demoly P, Lebel B, Messaad D et al (1999) Predictive capacity of histamine release for the diagnosis of drug allergy. Allergy 54:500–506

    Article  CAS  PubMed  Google Scholar 

  22. De Weck AL, Sanz ML, Gamboa PM et al (2009) Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. J Investig Allergol Clin Immunol 19:355–369

    PubMed  Google Scholar 

  23. Bavbek S, Dursun AB, Birben E et al (2009) Cellular allergen stimulation test with acetylsalicylic acid-lysine is not a useful test to discriminate between asthmatic patients with and without acetylsalicylic acid sensitivity. Int Arch Allergy Immunol 149:58–64

    Article  CAS  PubMed  Google Scholar 

  24. Kleine-Tebbe J, Erdmann S, Knol EF et al (2006) Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. Int Arch Allergy Immunol 141:79–90

    Article  PubMed  Google Scholar 

  25. Möbs C, Pfützner W (2014) Cellular in vitro diagnosis of adverse drug reactions. Allergo J Int 23:164–171

    Article  PubMed  PubMed Central  Google Scholar 

  26. Sachs B, Erdmann S, Baron JM et al (2002) Determination of interleukin-5 secretion from drugspecific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization. Clin Exp Allergy 32:736–744

    Article  CAS  PubMed  Google Scholar 

  27. Rozieres A, Hennino A, Rodet K et al (2009) Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 64:534–542

    Article  CAS  PubMed  Google Scholar 

  28. Fu M, Gao Y, Pan Y et al (2012) Recovered patients with Stevens-Johnson syndrome and toxic epidermal necrolysis maintain long-lived IFN-gamm and sFasL memory response. PLOS ONE 7:e45516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Britschgi M, Pichler WJ (2002) Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2:325–332

    Article  PubMed  Google Scholar 

  30. Zwodniak A, Lochmatter P, Yerly D et al (2010) In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases. Allergy 65:376–384

    Article  Google Scholar 

  31. Lammintausta K, Kortekangas-Savolainen O (2005) The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 152:968–974

    Article  CAS  PubMed  Google Scholar 

  32. Barbaud A, Reichert-Penetrat S, Trechot P et al (1998) The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 139:49–58

    Article  CAS  PubMed  Google Scholar 

  33. Pichler WJ, Tilch J (2004) The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59:809–820

    Article  CAS  PubMed  Google Scholar 

  34. Nyfeler B, Pichler WJ (1997) The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 27:175–181

    Article  CAS  PubMed  Google Scholar 

  35. Perez T, Dayer E, Girard JP (1995) Hypersensitivity reactions to drugs: correlation between clinical probability score and laboratory diagnostic procedures. J Investig Allergol Clin Immunol 5:276–282

    CAS  PubMed  Google Scholar 

  36. Naisbitt DJ, Nattrass RG, Ogese MO (2014) In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needs. Immunol Allergy Clin North Am 34:691–705

    Article  PubMed  Google Scholar 

  37. Beeler A, Zaccaria L, Kawabata T et al (2008) CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity. Allergy 63:181–188

    CAS  PubMed  Google Scholar 

  38. Sanz ML, Gamboa PM, Mayorga C (2009) Basophil activation tests in the evaluation of immediate drug hypersensitivity. Curr Opin Allergy Clin Immunol 9:298–304

    Article  CAS  PubMed  Google Scholar 

  39. Kano Y, Hirahara K, Mitsuyama Y et al (2007) Utility of the lymphocyte transformation test in the diagnosis of drug hypersensitivity: dependence on its timing and the type of drug eruption. Allergy 62:1439–1444

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Pfützner.

Ethics declarations

Interessenkonflikt

C. Möbs und W. Pfützner geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Möbs, C., Pfützner, W. Diagnostik von Arzneimittelüberempfindlichkeiten. Hautarzt 68, 19–28 (2017). https://doi.org/10.1007/s00105-016-3908-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-016-3908-x

Schlüsselwörter

Keywords

Navigation